Real world experience with Maribavir for the treatment of cytomegalovirus in solid organ transplant recipients

Clin Transplant. 2023 Apr;37(4):e14929. doi: 10.1111/ctr.14929. Epub 2023 Feb 15.

Authors

David C Sabatino¹, Jessica Hedvat¹, David M Salerno¹, Marcus R Pereira², Nicholas W Lange¹

Affiliations

¹ NewYork-Presbyterian Hospital, Department of Pharmacy, New York, New York, USA.
² Columbia University Vagelos College of Physicians and Surgeons, Department of Medicine, New York, New York, USA.

PMID: 36740886
DOI: 10.1111/ctr.14929

No abstract available

Keywords: cytomegalovirus; maribavir; solid organ transplant.

Publication types

Letter

MeSH terms

Antiviral Agents / therapeutic use
Cytomegalovirus
Cytomegalovirus Infections* / drug therapy
Cytomegalovirus Infections* / etiology
Humans
Organ Transplantation* / adverse effects
Transplant Recipients

Substances

maribavir
Antiviral Agents